Neuromod Devices' Lenire, a bimodal neuromodulation device, has received De Novo approval from the FDA to treat tinnitus. According to the company, Lenire is the first of its kind to receive FDA approval.
To mark Tinnitus Week (February 1-7, 2021), The British Irish Hearing Instrument Association (BIHIMA) announced the results of a survey that questioned its research panel of UK audiologists on the subject of tinnitus awareness.
The trial reportedly achieved its objectives by demonstrating a positive clinical signal for OTO-313 based on a TFI responder analysis, with a favorable safety profile, according to the company.
Funded through a National Institutes of Health (NIH) grant of $455,982, the project’s long-term goal is to construct a profile that can be used by healthcare providers and educators to identify individuals genetically at risk for chronic tinnitus and help them prevent the condition.
Read More
The randomized, double-blind, placebo-controlled Phase 1/2 study will include an initial safety cohort followed by an exploratory efficacy study that will enroll approximately 50 patients with subjective tinnitus.
Read More
InnerScope and Erchonia are reported to have received approval under FDA regulations from an Institutional Review Board (“IRB”) for the initial clinical trial of the effect of Erchonia’s low-level laser therapy technology on the relief of tinnitus symptoms.
Read More
Douglas Beck, AuD, interviews Dr Searchfield who is one of the world’s leading experts on the cognitive processes involved in tinnitus perception and innovative technology for the management of hearing loss and tinnitus. Topics include the possible origins of tinnitus, tools for helping patients, cognitive behavioral therapy (CBT), internet-based CBT, and more.
Read More
Lim’s work has a strong focus on the improvement of invasive and non-invasive neurostimulation approaches for treating unmet medical needs in hearing and other therapeutic areas.
Read More
As we continue to support the needs of the tinnitus patient and practitioner—from sound generators to therapy approaches—it is important to maintain flexibility in treatment. This article looks at the three most-common tinnitus treatment approaches used within a clinic or with an individual patient. Recent evidence suggests the therapist is 9 to 10 times more important to the outcome of therapy than the specific treatment approaches, and new tools like Oticon’s Tinnitus SoundSupport are providing better options in the treatment of tinnitus patients with hearing aids.
Read More
Mild hearing loss from exposure to less than one hour of loud noise leads to a reorganization of circuits in a key midbrain structure of the auditory system in mice, finds new research published in ‘The Journal of Neuroscience,’ the Society of Neuroscience announced.
Read More
Following last month’s interview with Richard Tyler, PhD, we turn our attention to another world expert in tinnitus, James A. Henry, PhD, a research career scientist at the VA National Center for Rehabilitative Auditory Research, and recipient of the 2016 Paul B. Magnuson Award for his innovative work on the treatment and management of tinnitus—the highest honor for VA rehabilitation investigators.
Read More
A new multi-lingual devised theatre production, Salonica, by Equal Voices Arts Company has been invited overseas to perform and tour in the UK, Serbia, and Montenegro, the University of Waikato announced.
Read More
As part of its research and development program, “Horizon 2020,” the European Union (EU) is making 3.8 million euros available for the European School for Interdisciplinary Tinnitus Research (ESIT)—an education program funded by the EU in order to promote tinnitus research in Europe—in order to gather data on a systematic interdisciplinary basis, to research new treatment methods, and to train 15 young scientists for work in the field, ESIT announced.
Read More
A team of researchers from Wayne State University has developed a behavioral tool that may significantly aid in understanding the underlying mechanisms of tinnitus, ultimately leading to new drugs and treatment methods, the school announced.
Read More
Using counseling, amplification, fractal tones, relaxation strategies, sleep management, and many elements associated with TRT and CBT for an individualized comprehensive tinnitus management program.
Read More
The size of the tinnitus population in the United States is nearly 30 million people—or about 10% of the entire population—and the incidence of tinnitus is as high as 26.7% for people ages 65-84 years. Data in this article also confirm that the provision of hearing aids offers substantial benefit to a significant number of people suffering from tinnitus. Evidence also suggests that this information should be more widely disseminated in the audiological and medical communities.
Read More